Assessment of Chemotherapy Response in Ewing Sarcoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Radiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 27755931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.

  2016cited by this paper
• Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study.

  2010cited by this paper
• Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters

  2010cited by this paper
• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee

  2008cited by this paper
• Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

  2007cited by this paper

• Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS)

  2024cites this paper
• Multiparametric MRI evaluation of bone sarcomas in children

  2022cites this paper
• Quantitative analysis of image metrics for reduced and standard dose pediatric 18F-FDG PET/MRI examinations.

  2019cites this paper